Sickle cell disease (SCD) and HIV have a major burden on the health of impoverished communities all over the world. Of the 38 million people living with HIV all over the world, approximately 95% reside within developing countries, with 67% in sub-Saharan Africa, half of whom are living without any treatment. Fifteen million babies will … Continue reading NIH collaboration aims to develop affordable gene therapies for sickle cell disease and HIV
Dr. Francis Collins
Turning the corner with the FDA and NIH; CIRM creates new collaborations to advance stem cell research
This blog is part of the Month of CIRM series on the Stem Cellar A lot can change in a couple of years. Just take our relationship with the US Food and Drug Administration (FDA). When we were putting together our Strategic Plan in 2015 we did a survey of key players and stakeholders at … Continue reading Turning the corner with the FDA and NIH; CIRM creates new collaborations to advance stem cell research
CIRM & NIH: a dynamic duo to advance stem cell therapies
There’s nothing more flattering than to get an invitation, out of the blue, from someone you respect, and be told that they are interested in learning about the way you work, to see if it can help them improve the way they work. That’s what happened to CIRM recently. I will let Randy Mills, who … Continue reading CIRM & NIH: a dynamic duo to advance stem cell therapies
Brave new world or dark threatening future: a clear-eyed look at genome editing and what it means for humanity
Is this the face of the future? “Have you ever wished that there were something different about yourself? Maybe you imagined yourself taller, thinner or stronger? Smarter? More attractive? Healthier?” That’s the question posed by UC Davis stem cell researcher (and CIRM grantee) Paul Knoepfler at the start of his intriguing new book ‘GMO … Continue reading Brave new world or dark threatening future: a clear-eyed look at genome editing and what it means for humanity
The Stem Cellar 